{"id":"https://openalex.org/W2325757838","doi":"https://doi.org/10.1158/1538-7445.am10-4749","title":"Abstract 4749: Genetic signature of malignant glioma is associated with responsiveness to autologous tumor lysate-pulsed dendritic cell vaccination + TLR agonists","display_name":"Abstract 4749: Genetic signature of malignant glioma is associated with responsiveness to autologous tumor lysate-pulsed dendritic cell vaccination + TLR agonists","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2325757838","doi":"https://doi.org/10.1158/1538-7445.am10-4749","mag":"2325757838"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-4749","doi":"https://doi.org/10.1158/1538-7445.am10-4749","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-4749","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010449744","display_name":"Robert Michael Prins","orcid":"https://orcid.org/0000-0002-6282-6583","observed_orcids":["https://orcid.org/0000-0002-6282-6583"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Prins","raw_affiliation_strings":["1David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106037413","display_name":"Horacio Soto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Horacio Soto","raw_affiliation_strings":["1David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058950927","display_name":"Vera Konkankit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vera Konkankit","raw_affiliation_strings":["1David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016190247","display_name":"William H. Yong","orcid":"https://orcid.org/0000-0002-0879-0209","observed_orcids":["https://orcid.org/0000-0002-0879-0209"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William H. Yong","raw_affiliation_strings":["1David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073896107","display_name":"Stanley F. Nelson","orcid":"https://orcid.org/0000-0002-2082-3114","observed_orcids":["https://orcid.org/0000-0002-2082-3114"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanley F. Nelson","raw_affiliation_strings":["1David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079316205","display_name":"Linda M. Liau","orcid":"https://orcid.org/0000-0002-4053-0052","observed_orcids":["https://orcid.org/0000-0002-4053-0052"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda M. Liau","raw_affiliation_strings":["1David Geffen School of Medicine at UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1David Geffen School of Medicine at UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"4749","last_page":"4749"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8804000020027161,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8804000020027161,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.11829999834299088,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-grade-glioma","display_name":"high-grade glioma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tumor-lysate","display_name":"tumor lysate","score":0.9210000038146973},{"id":"https://openalex.org/keywords/imiquimod","display_name":"imiquimod","score":0.9760000109672546},{"id":"https://openalex.org/keywords/poly-iclc","display_name":"poly-ICLC","score":0.8230000138282776},{"id":"https://openalex.org/keywords/toll-like-receptor-agonists","display_name":"TLR agonists","score":0.9210000038146973},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.8040000200271606},{"id":"https://openalex.org/keywords/mesenchymal-signature","display_name":"mesenchymal signature","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.824999988079071},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.6349999904632568},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.44600000977516174},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5809999704360962},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7879552841186523},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6870163679122925},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.5795783996582031},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.54571932554245},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4896586537361145},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4571191966533661},{"id":"https://openalex.org/C2779112978","wikidata":"https://www.wikidata.org/wiki/Q423417","display_name":"Imiquimod","level":2,"score":0.45039457082748413},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4467315971851349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36185482144355774},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34763747453689575},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3456471264362335}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-4749","doi":"https://doi.org/10.1158/1538-7445.am10-4749","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-4749","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2595296583","https://openalex.org/W2266553968","https://openalex.org/W7095692795","https://openalex.org/W3111281030","https://openalex.org/W2133499518","https://openalex.org/W3012987173","https://openalex.org/W4396730983","https://openalex.org/W1989207092","https://openalex.org/W2148584717","https://openalex.org/W7098345325"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"We":[2],"previously":[3,240],"reported":[4],"that":[5],"the":[6,65,85,287,326,340,345],"toll-like":[7,86],"receptor":[8,87],"(TLR)-7":[9],"agonist,":[10],"imiquimod,":[11],"could":[12],"enhance":[13],"dendritic":[14,79],"cell":[15,80],"activation":[16],"and":[17,52,99,116,165,182,217,282,308],"migration,":[18],"as":[19,21,226],"well":[20],"stimulate":[22],"T":[23],"cell-mediated":[24],"anti-tumor":[25],"immune":[26,55,166],"responses":[27,56],"in":[28,57],"a":[29,37,112],"murine":[30],"glioma":[31],"model.":[32],"To":[33],"translate":[34],"these":[35,329],"findings,":[36],"Phase":[38],"I":[39],"clinical":[40,73],"trial":[41,74],"was":[42,156,210],"initiated":[43],"to":[44,248,321,324],"evaluate":[45],"this":[46,68,233],"strategy":[47],"for":[48,93,161,188,213,220,348],"its":[49],"feasibility,":[50],"safety,":[51],"induction":[53],"of":[54,67,200,328,339,344],"patients":[58,94,103,138,169,216,228,253,265,304],"with":[59,84,95,118,127,143,170,197,254,266,290,305],"malignant":[60,96],"glioma.":[61,97],"Herein,":[62],"we":[63],"report":[64],"results":[66],"phase":[69],"I,":[70],"dose":[71],"escalation":[72],"using":[75],"autologous":[76,124],"tumor":[77,128,152,173,277,288,292],"lysate-pulsed":[78],"(DC)":[81],"vaccination,":[82],"supplemented":[83],"agonists,":[88],"imiquimod":[89,144],"or":[90,121,145,154,203,257,275,297],"poly":[91,146],"ICLC,":[92],"Patients":[98,158],"Methods:":[100],"Twenty-two":[101],"glioblastoma":[102,236],"(15":[104],"newly":[105,214],"diagnosed,":[106],"7":[107],"recurrent)":[108],"were":[109,134,159,186,194,245],"enrolled":[110],"into":[111],"multi-cohort":[113],"dose-escalation":[114],"study":[115],"treated":[117],"1,":[119],"5,":[120],"10":[122],"million":[123],"DC":[125,192],"pulsed":[126],"lysate.":[129],"Three":[130],"biweekly":[131],"intradermal":[132],"vaccinations":[133,141,193],"initially":[135],"administered.":[136],"Subsequently,":[137],"received":[139],"booster":[140],"together":[142],"ICLC":[147],"every":[148],"three":[149],"months":[150,212,219],"until":[151],"progression":[153],"lysate":[155],"depleted.":[157],"monitored":[160],"adverse":[162,205],"events,":[163],"survival,":[164,263],"responses.":[167],"For":[168],"available":[171],"pre-treatment":[172],"and/or":[174],"PBMC,":[175],"microarray-based":[176],"hierarchical":[177],"clustering,":[178],"lymphocyte":[179],"immunohistochemistry,":[180],"FACS":[181],"cytokine":[183],"bead":[184],"arrays":[185],"performed":[187,323],"monitoring":[189],"purposes.":[190],"Results:":[191],"not":[195],"associated":[196],"any":[198],"evidence":[199],"dose-limiting":[201],"toxicity":[202],"serious":[204],"effects.":[206],"The":[207],"median":[208],"survival":[209],"35":[211],"diagnosed":[215],"11":[218],"recurrent":[221],"patients,":[222],"but":[223],"still":[224,230],"increasing":[225],"several":[227],"are":[229],"alive":[231],"at":[232],"point.":[234],"Typical":[235],"gene":[237,299],"expression":[238,300],"signatures,":[239],"characterized":[241],"by":[242],"our":[243,249],"group,":[244],"found.":[246],"Contrary":[247],"previous":[250],"reports,":[251],"however,":[252],"proliferative":[255],"(Pro)":[256],"mesenchymal":[258],"(Mes)":[259],"signatures":[260,269,301],"exhibited":[261],"prolonged":[262],"while":[264],"pro-neural":[267],"(PN)":[268],"did":[270],"not.":[271],"Pre-treatment":[272],"Pro,":[273,295],"Mes":[274,296],"Pro/Mes":[276,298],"sections":[278],"had":[279],"increased":[280],"CD3":[281],"CD8":[283],"positive":[284],"cells":[285],"within":[286],"compared":[289],"PN":[291],"sections.":[293],"Conclusions:":[294],"may":[302,310],"identify":[303],"pre-existing":[306],"immunity":[307],"who":[309],"benefit":[311],"from":[312],"immune-based":[313],"vaccination":[314],"studies.":[315],"However,":[316],"prospective":[317],"studies":[318],"will":[319],"need":[320],"be":[322],"establish":[325],"validity":[327],"findings.":[330],"Citation":[331],"Format:":[332],"{Authors}.":[333],"{Abstract":[334],"title}":[335],"[abstract].":[336],"In:":[337],"Proceedings":[338],"101st":[341],"Annual":[342],"Meeting":[343],"American":[346],"Association":[347],"Cancer":[349,359],"Research;":[350],"2010":[351],"Apr":[352],"17-21;":[353],"Washington,":[354],"DC.":[355],"Philadelphia":[356],"(PA):":[357],"AACR;":[358],"Res":[360],"2010;70(8":[361],"Suppl):Abstract":[362],"nr":[363],"4749.":[364]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}